Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis

NCT04269954 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT04269954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04269954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Batroxobin Combined With Anticoagulation in Cerebral Venous Sinus Thrombosis
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Unknown status
Start date
March 1, 2020
Completion date
December 1, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

batroxobin, cerebral venous sinus thrombosis